sector medic suppli devic
messag schedul report fiscal earn march ahead
result updat estim recent currenc interest rate
fluctuat latest read contact len competit landscap
remain concern histor advantag lens erod amid increas
focu categori competitor consensu forecast appear beatabl
view expect strong fx tailwind drive upsid street number
see modest upsid potenti street estim coopervis
model call sale yoy organ vs current consensu
forecast follow valeant result earlier week know
three major competitor saw contact len sale rise underli basi
calendar also came yoy comp
tougher alcon bausch strong perform close
estim world-wide contact len market grew modestli
growth first nine month year expect return
market growth rare quarter under-perform compani
face tough comp america asia pacif
result think like delta growth broader market remain
rel narrow elsewher coopersurg estim line street
look see whether paragard top rel mute expect
first quarter part portfolio bottom line project adjust ep
vs consensu adjust currenc paragard accret
forecast impli underli earn growth
overal expect combin fx tax extens mdet
suspens push estim higher current rate estim currenc could
tailwind compar manag guidanc
origin outlook also assum medic devic excis tax would return
applic small portion revenu would still cost
compani math final cfo al white comment januari
compani tax rate like come origin forecast
everi reduct ad bottom line neg side higher
interest rate could cost addit year float rate
debt take account estim compani
addit earn cushion rel first gave outlook expect
manag reinvest upsid rais ep estim
think like guidanc
consensu move higher come next week call new forecast
impli full year earn growth report basi underli gain
stock valuat start look entic sure
enough launch coverag june share trade
estim level view rich sinc howev stock
vs gain earn estim increas
net result multipl today sit importantli
though increas earn power come larg inorgan sourc fx
paragard underli ep estim actual declin period
constant currenc revenu forecast essenti unchang unlik
market reward fx-driven earn upsid time around
overshadow concern grow competit pressur lens expect
narr evolv import determin stock perform
balanc
page analyst certif import disclosur
straddl line healthcar consum product contact
len women health busi coopervis portfolio uniqu posit take
advantag two tailwind drive contact len market growth today shift
premium len materi particular silicon hydrogel increas popular
daili dispos lens recent year leverag broadest daili sih
offer market lead posit monthli sih categori continu
long histori above-market growth compani captur averag
market share per year sinc expect gain moder go forward
backdrop competit contact len market believ cooper
remain well posit sustain growth
elsewher paragard deal add scale coopersurg grow women health
presenc often overlook investor expect csi account
overal revenu growth fuel
primarili compani invest half dozen deal
build lead posit ivf genet test market follow recent
acquisit paragard intrauterin devic believ long-term
fundament market appeal see grow scale csi neg
broader invest case complic stori believ
investor would prefer look sole contact len play
dust settl paragard see sustain top
bottom line grower outlook believ fulli reflect stock
current level limit near-term potenti multipl expans view prefer
wait better entri point consid becom posit stock
valu primarili price-to-earnings basi use repres group mid-cap
med-tech name similar growth characterist comp base guggenheim
factset consensu estim group current trade ntm ep
ebitda repres modest premium multipl
respect view discount appropri given extent cooper
recent earn momentum driven inorgan factor particularli fx
result assign share neutral rate
upsid risk rate includ faster expect contact len market growth due
rise sih penetr daili len adopt increas share gain
busi better expect growth/accret paragard
downsid risk rate includ better anticip traction competit
contact len launch weaken macroeconom backdrop put pressur
cooper busi see discretionari med-tech market
potenti exposur tax reform rise interest rate
page analyst certif import disclosur
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
